ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
ResMed (RMD) Tops Q1 EPS by 24c, Revenues Beat
October 29, 2020 4:50 PM EDTResMed (NYSE: RMD) reported Q1 EPS of $1.27, $0.24 better than the analyst estimate of $1.03. Revenue for the quarter came in at $751.9 million versus the consensus estimate of $710.73 million.
First Quarter 2021 Highlights
All... More



